Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magnafolate, the brand name for Lianyungang Jinkang Pharmaceutical Technology Co., Ltd., is a specialized life sciences company focused on the research and manufacturing of high-purity folate derivatives. The company is a global leader in the production of L-5-Methyltetrahydrofolate Calcium (L-5-MTHF-Ca), marketed under the brand Magnafolate®. Their proprietary C-crystalline technology provides superior stability, safety, and bioavailability compared to traditional folic acid and amorphous folate forms. Magnafolate® is primarily used as an active ingredient in nutraceuticals, pharmaceuticals, and functional foods to address MTHFR gene mutations and support maternal and cardiovascular health. The company operates under strict GMP standards and serves a diverse international market in the healthcare and nutrition sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Magnafolate.